Labshake search
Citations for Stemcell Technologies :
701 - 750 of 1893 citations for Human Brain Derived Neurotrophic Factor BDNF ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD4+ T cells (Stem Cell Technologies, 200-0165) were cultured in ImmunoCult-XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2023Quote: ... human iPSCs were passaged with Accutase (Stem Cell Technologies, Vancouver, Canada) and re-plated at a density of 1 to 2×105 per cm2 in growth factor reduced Matrigel (Corning Incorporated ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10% NeuroCult™ Proliferation Supplement (Human) (STEMCELL Technologies, 05753), heparin solution (final concentration ...
-
bioRxiv - Bioengineering 2023Quote: ... 0.5ug/mL human recombinant Thrombopoietin (TPO) (StemCell Technologies, Cat. No. 78210), and 1% PSG (Thermofisher ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD8+ T cells (Stem Cell Technologies, 200-0164) were cultured in ImmunoCult XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Developmental Biology 2024Quote: Primed H9 human ESC were cultured according in mTeSR1 (StemCell Technologies) according to the manufacturer’s guidance ...
-
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer CellsbioRxiv - Immunology 2023Quote: ... ImmunoCult™ human CD3/CD28/CD2 T-cell activator (StemCell Technologies) was used to activate isolated T cells in vitro for 2 days following the manufacturer’s recommendations.
-
bioRxiv - Bioengineering 2024Quote: ... and 6 × 103 human bone marrow CD34+ cells (STEMCELL Technologies, 70002.3) into a collagen-based hydrogel according to the protocol described previously (49 ...
-
bioRxiv - Bioengineering 2024Quote: ... or ReLeSRTM human PSC selection and passaging reagent (Stemcell Technologies; 05872). The differentiation of iPSCs into foregut cells was performed using previously published protocols13,21 ...
-
bioRxiv - Cancer Biology 2024Quote: The RosetteSep™ Human CD45 Depletion Cocktail (Catalog #15112, StemCell Technologies) was used in this study to enrich cancer cells spiked into whole blood ...
-
bioRxiv - Cancer Biology 2022Quote: ... all the unwanted cells were labelled with magnet conjugated antibody cocktail which is separated using their EasySep magnetic stand leaving CD4 or CD8 cell in suspension using the vendor supplied EasySep Human CD4/CD8 T Cell Iso Kit (Stem Cell Technologies, 17952 for CD4 and 17953 for CD8). This negative selection approach results in isolation of untouched CD8 or CD4 T cells and stored frozen with 10% DMSO (MP Biomedicals ...
-
bioRxiv - Cancer Biology 2022Quote: ... BT179 and BT333 were maintained in NeuroCult proliferation medium (human) (StemCell Technologies) with 20 ng/ml EGF ...
-
bioRxiv - Molecular Biology 2021Quote: ... were suspended in Intesticult (INT) human organoid growth medium (Stem Cell Technologies) proliferation medium ...
-
bioRxiv - Neuroscience 2019Quote: ... ImmunoCult Human CD3/CD28 T cell Activator and 20ng rhIL2 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Neuroscience 2019Quote: ... anti-human CD40 antibody (clone 5C3) and 20 ng rhIL4 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Immunology 2021Quote: PBMCs were isolated from six human peripheral blood leukapheresis packs (STEMCELL Technologies) using Ficoll gradient density centrifugation ...
-
bioRxiv - Bioengineering 2021Quote: ... human iPSCs were cultured in mTeSR+ stem cell medium (Stem Cell Technologies) on Matrigel coated plates (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2021Quote: ... TNF alpha (0.5ng/mL final concentration in PBS, human recombinant, Stemcell Tech) was added to half of the wells ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 20 ng/ml human recombinant bFGF (Stem Cell Technologies cat# 78003). For 10 gBlocks pool ...
-
bioRxiv - Cancer Biology 2022Quote: ... and CD66b+ cells (RosetteSep Human CD45 Depletion Cocktail, STEMCELL Technologies Inc., Canada). Blood samples were incubated with RosetteSep Cocktail (50 μl per 1 ml blood ...
-
bioRxiv - Cell Biology 2022Quote: Endoderm induction was quantified using anti-human CD184(CXCR4)-PE (StemCell Technologies) and anti-human CD117(CKIT)-APC (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2021Quote: Leukapheresis products from anonymous healthy human donors were purchased from STEMCELL Technologies, Inc ...
-
bioRxiv - Immunology 2022Quote: ... Human PBMCs were isolated by using Lymphoprep (Stemcell Technologies, Vancouver, BC, Canada) gradient centrifugation ...
-
bioRxiv - Bioengineering 2020Quote: Human hematopoietic progenitors were cultured in StemSpan SFEM I (Stem Cell Technologies) supplemented with human stem cell factor (hSCF ...
-
bioRxiv - Immunology 2020Quote: ... and 5 ng/mL recombinant human IL-15 (StemCell Technologies, Cat # 78031). Recombinant SARS-CoV-2 receptor binding domain was coated onto MaxiSorp 96-well plates (Thermo Scientific ...
-
bioRxiv - Systems Biology 2020Quote: Monocytes were enriched using RosetteSep human monocyte enrichment cocktail (Stem Cell Technologies) and purified by density gradient centrifugation ...
-
bioRxiv - Cell Biology 2020Quote: ... Human iPSCs were dissociated into single cells using Accutase (Stem Cell Technologies) at 37℃ for 10 min and then were seeded on to a vitronectin-coated six-well plate at 3×105 cell/well in mTeSR1 supplemented with 5μM ROCK inhibitor (Y-27632 ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... Human iPSCs were originally cultured in mTesR medium (STEMCELL Technologies, Cambridge, MA) and more recently in StemFlex medium (ThermoFisher ...
-
bioRxiv - Biochemistry 2019Quote: ... Commercial human blood plasma was purchased from STEMCELL Technologies (cat. no. 70039). Primary pediatric B-ALL and AML patient mononuclear cells enriched from bone marrow aspirates ...
-
bioRxiv - Immunology 2019Quote: RosetteSep Human CD4+ T Cell Enrichment Cocktail with SepMate-15 (STEMCELL Technologies) was used to remove non-CD4+ T-cells from fresh whole blood ...
-
bioRxiv - Bioengineering 2021Quote: Human ESC line H1 was maintained using mTeSR medium (Stemcell Technologies, 85850) on 1:200 Geltrex (Thermo fisher ...
-
bioRxiv - Cell Biology 2020Quote: Human iPSCs (WTc line1) were maintained in mTESR or mTESR+ (STEMCELL Technologies) on Matrigel (8 μg/ml ...
-
bioRxiv - Immunology 2021Quote: ... and human BAFF(71) in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 µg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Cancer Biology 2023Quote: ... human iPSCs grown on a Matrigel-coated surface in mTeSR1 (STEMCELL Technologies) were dissociated into single cells with Accutase (Life Technologies ...
-
bioRxiv - Immunology 2023Quote: Frozen human peripheral blood CD19+ B cells were purchased from StemCell Technologies and thawed per manufacturer’s instructions ...
-
bioRxiv - Immunology 2023Quote: ... or RosetteSepTM Human CD4+ T Cell Enrichment Cocktail (StemCell technologies, Vancouver, Canada) and centrifugation over a buoyant density medium (Lympholyte Cell Separation Medium ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were re-suspended with MammoCult Human Medium (Stem cell technology #05620), and then 5000 cells per well were seeded on 6 well Ultra-low adherent plate (Corning #3471 ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood mononuclear cells were obtained from STEMCELL Technologies (cat#700.25.1). PBMCs were cultured and maintained in RPMI1640 with 10% fetal bovine serum (FBS ...
-
bioRxiv - Immunology 2023Quote: Leukapheresis product (leukopaks) from healthy human donors were obtained from Stemcell Technologies shipped on wet ice ...
-
bioRxiv - Bioengineering 2023Quote: ... and ImmunoCult Human CD3/CD28 T Cell Activator (Stem Cell Technologies, 10971) was added at 5 μL/mL to a total volume to 200 μL ...
-
bioRxiv - Molecular Biology 2023Quote: ... supplemented with 20 ng/ml recombinant human EGF (STEMCELL Technologies, cat# 78006). For passaging ...
-
bioRxiv - Bioengineering 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (STEMCELL Technologies, Cat# 78036.3). To prepare 3 mg/ml collagen-I gel ...
-
bioRxiv - Bioengineering 2024Quote: ... and ImmunoCult™ Human CD3/CD28 T Cell Activator (STEMCELL TECHNOLOGIES, #10971) for a duration of 3 days ...
-
bioRxiv - Molecular Biology 2024Quote: Human ABCs were cultured in PneumaCult Ex Plus medium (StemCell Technologies #05040) with addition of ROCK inhibitor 10 µM (Y-27632 ...
-
bioRxiv - Cancer Biology 2021Quote: ... Tissues were washed once in NeuroCult NS-A Basal Medium (human; STEMCELL Technologies), and PDOs were washed in the same media at room temperature for 15 min with rocking ...
-
bioRxiv - Immunology 2021Quote: Donor-matched human Treg and Tconv cells (Stemcell Technologies, 70096, Vancouver, BC, Canada) were thawed and stained with CellTrace Violet (C34571 ...
-
Understanding immune-driven brain aging by human brain organoid microphysiological analysis platformbioRxiv - Bioengineering 2022Quote: Human embryonic stem cells were dissociated into single cells using ReLeSR (Stemcell Technologies) treatment ...
-
bioRxiv - Cell Biology 2022Quote: ... cryopreserved CD4+ human cord blood T cells were purchased from Stem Cell Technologies. T cells were isolated from mixed T and B cell cultures using nylon wool separation96 ...
-
bioRxiv - Evolutionary Biology 2022Quote: ... NPC human primary cells and supporting culture ingredients were purchased from STEMCELL technologies and the manufacturer’s instructions were followed.